Molecular Genetics and Metabolism Reports
Volume 4 • Issue 4
- ISSN: 2214-4269
- 5 Year impact factor: 2
- Impact factor: 1.8
Molecular Genetics and Metabolism Reports is a peer-reviewed Gold Open Access journal dedicated to advancing the understanding of inborn metabolic diseases and metabolic dy… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quoteMolecular Genetics and Metabolism Reports is a peer-reviewed Gold Open Access journal dedicated to advancing the understanding of inborn metabolic diseases and metabolic dysfunction in Mendelian conditions through innovative research in molecular genetics and metabolic pathways. As its companion title Molecular Genetics and Metabolism, the journal is committed to publishing high-quality research.
The journal welcomes original full-length research articles, short communication (single point, single figure article), case reports of significant interest, case series (several cases with the same diagnosis), reviews, and letters to the editor. Submissions may involve human patients, animal models, cellular systems, and computational frameworks.
The journal mainly considers articles on translational and clinical investigations, including:
Advances in metabolic engineering, gene therapy, and personalized medicine, including novel therapeutic approaches.
Evaluation of drug delivery systems and gene editing technologies.
Long-term follow-up studies on the efficacy and safety of gene and enzyme replacement therapies.
Clinical trials and longitudinal studies assessing early interventions and treatment strategies.
Comparative effectiveness research of existing therapies and interventions.
Patient-centered research focused on management, quality of life, and healthcare needs.
Clinical guidelines and treatment protocols for inherited metabolic diseases.
Development and validation of novel methods in newborn screening and diagnostic approaches.
Discovery and validation of biochemical markers for early diagnosis and prognosis of inherited metabolic diseases.
Characterization of new phenotypes and novel genetic disorders.
Research on epigenetic influences, microbiome interactions, and nutritional genomics.
Integration of multi-omics data for comprehensive disease modeling and therapy development.
Implementation of pharmacogenomics and precision medicine for optimizing treatments.
Advances in telemedicine and digital health for managing inherited metabolic diseases.
Assessment of mental health and cognitive outcomes in patients with inherited metabolic disorders.
Ethical, legal, and social implications (ELSI) of genetic testing and interventions.
While the journal primarily focuses on translational and clinical research, basic research articles may be considered in some instances.
Studies primarily focused on acquired metabolic conditions, such as metabolic syndrome, obesity, lifestyle-associated metabolic disorders, non-inherited cancers, or other multifactorial metabolic diseases, are outside the scope of the journal.
Authors are also encouraged to submit to the journal’s companion title, Molecular Genetics and Metabolism, which welcomes high-quality studies on the fundamental mechanisms of inherited metabolic diseases in addition to translational studies.
- ISSN: 2214-4269
- Volume 4
- Issue 4
- 5 Year impact factor: 2
- Impact factor: 1.8